Results

Total Results: 406 records

Showing results for "company".

221. Using Deliberative Methods to Engage Patients, Consumers, and the Public (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-how-to-webinar-text-only.pdf
     December 06, 2011 - Using Deliberative Methods to Engage Patients, Consumers, and the Public Slide 1 Using Deliberative Methods to Engage Patients, Consumers, and the Public Agency for Healthcare Research and Quality Community Forum December 6, 2011 Speaker notes: Welcome, everyone, to this webinar about using deliberative met…

222. Innovations in Stakeholder Engagement Conference Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/innovations_in_stakeholder_engagement_conference_summary2.pdf
     October 01, 2011 - Innovations in Stakeholder Engagement Conference Summary Innovations in Stakeholder Engagement Conference Summary 2 AHRQ Community Forum Overview of Types of Online Collaborative Platforms Chris Haller, Founder and CEO, Urban Interactive Studios Online collaborative platforms provide an avenue for individua…

223. Noninvasive Diagnostic Techniques for the Detection of Skin Cancers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_technical-brief.pdf
     December 01, 2014 - Marchionda 2010 indicated that the lack of reimbursement from an insurance company would result in unwillingness … FDA clearance status for noninvasive skin cancer diagnostic devices Device name Company (country) … FDA clearance status for noninvasive skin cancer diagnostic devices (continued) Device name Company

224. Effectiveness of Treatments for Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
     May 09, 2016 - Effexor (Venlafixine) Pfizer Pristiq (Desvenlafaxine) Pfizer Cymbalta (Duloxetine) Eli Lilly and Company

225. S149 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
     October 01, 2007 - patients and their dependents whose healthcare utilization data is collected by i3Innovus, an In- genix company

226. Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel - Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
     November 01, 2017 - Insys Development Company Inc.

227. Engaging Patients in Information Sharing and Data Collection: The Role of Patient-Powered Registries and Research Networks (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_white-paper.pdf
     September 01, 2013 - Partners for Patient Health Innovation Challenge, funded by Sanofi US, an international pharmaceutical company

228. March 3rd Impact of Healthcare Algorithms on Racial and Ethnic Disparities in Healthcare (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-3.pdf
     July 01, 2023 - www.healthit.gov/form/healthit-feedback-form https://twitter.com/onc_healthit https://www.linkedin.com/company

229. Project Name: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
     October 25, 2011 - Project Name: Source: www.effectivehealthcare.ahrq.gov Published Online: October 25, 2011 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Comparative Effectiveness of Diagnosis and Treatment of Obstructive Sleep Apnea in Adults Draft revi…

230. Options for Developing a Web-Based Forum on Patient Registries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
     May 01, 2014 - sites that have a primary purpose of sharing information with the public (e.g., marketing a private company

231. Healthcare Industry Waste and Lifecycle Assessment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-protocol.pdf
     August 23, 2023 - Healthcare Industry Waste and Lifecycle Assessment Evidence-based Practice Center Technical Brief Protocol Project Title: Healthcare Industry Waste and Lifecycle Assessment I. Background and Objectives for the Technical Brief Clinicians are increasingly aware of the environmental impacts of healthcare pr…

232. Disposition of Comments Report for Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
     January 27, 2014 - Disposition of Comments Report for Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities Draft review av…

233. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
     January 01, 2020 - New York (NY): The New York Times Company; 2014 Apr 26 [accessed 2014 May 05]. [7 p].

234. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - However, LinkedWellness’ company Web site has been nonfunctional since early 2015, and SPARX’s New

235. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
     September 01, 2011 - Was there any consideration given to stratifying the analyses according to whether studies were drug-company

236. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - (Amgen), a science-based, patient-driven company that is committed to using evidence-based science and

237. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - (Baltimore, MD) holds an exclusive license from Auckland UniServices, Ltd., the commercialization company

238. ASSESSING THE QUALITY OF INCLUDED STUDIES (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
     June 02, 2011 - Boston: Houghton Mifflin Company; 1979. 14. Guyatt GH, Oxman AD, Vist GE, et al.

239. Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
     December 20, 2018 - on behalf of BMS) Evidence Summary Bristol-Myers Squibb (BMS) is a global biopharmaceutical company

240. Trauma-Child-Interventions Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_executive.pdf
     February 01, 2013 - Eli Lilly and Company. Prozac package insert. Section 12.3. Pharmacokinetics. 45. … Eli Lilly and Company. Prozac package insert. Section 5.12.